01—Abstract
Summary
Summary of the 10-Q filed May 2, 2024. Cited figures are marked; the original filing is the authoritative source.
MetLife Inc. reported a strong first quarter for 2024, demonstrating significant year-over-year improvement in key financial metrics.
Net income available to common shareholders surged to $800 milliona, a substantial increase from $14 million in the prior year's first quarter. This growth was driven by a favorable shift in net investment gains and a significant reduction in net derivative losses, alongside improved market conditions impacting market risk benefit remeasurements. Adjusted earnings also saw a healthy increase to $1.33 billion, up from $1.18 billion in Q1 2023, reflecting underlying business performance and favorable market factors.
The company maintained a strong capital position and continued its share repurchase program, repurchasing over $1.17 billionb in common stock during the quarter. Total assets stood at $677.6 billion at the end of the quarter, with total liabilities of $648.8 billion, resulting in total equity of $28.8 billion. The company's diversified business segments, including Group Benefits, RIS, Asia, Latin America, EMEA, and MetLife Holdings, collectively contributed to this performance, with notable strength observed in the Asia and Latin America segments, driven by volume growth and favorable market conditions, partially offset by foreign currency fluctuations.
Looking ahead, MetLife's strategic focus on managing its investment portfolio for long-term value and its robust capital management strategy are expected to support continued financial performance. The company's ability to navigate evolving economic conditions and regulatory landscapes, as evidenced by this quarter's results, positions it well for sustained shareholder value creation. Investors should monitor the company's ongoing progress in its strategic initiatives, its response to market interest rate movements, and its international segment performance.
02—Key points
Key Highlights
- MetLife reported a substantial increase in Net Income Available to Common Shareholders to $800 million for Q1 2024, up from $14 million in Q1 2023.
- Adjusted Earnings increased to $1.33 billion in Q1 2024, compared to $1.18 billion in Q1 2023, indicating solid underlying business performance.
- Total Revenues increased to $16.06 billion in Q1 2024 from $15.39 billion in Q1 2023, driven by higher net investment income and premiums.
- Total Expenses decreased to $15.01 billion in Q1 2024 from $15.13 billion in Q1 2023, benefiting from favorable market risk benefit remeasurements.
- The company repurchased approximately $1.17 billion of its common stock during Q1 2024, demonstrating a commitment to returning capital to shareholders.
- Total Assets stood at $677.58 billion as of March 31, 2024, while Total Liabilities were $648.78 billion.
- The company saw strong performance in its Asia and Latin America segments, with adjusted earnings increasing by $143 million and $18 million, respectively, driven by volume growth and favorable market factors.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2024filed May 2, 2024Financial Statements
Q1 FY2024 against Q1 FY2023
| Line item | Q1 FY2024Q1 FY2023 | Change |
|---|---|---|
| Revenue | $16.06B$15.39B | +4.3% |
| Operating Expenses | $3.22B$3.06B | +5.2% |
| Operating Income | $1.40B— | — |
| Net Income | $875.00M$85.00M | +929.4% |
| EPS (Basic) | $1.11$0.02 | +5450.0% |
| EPS (Diluted) | $1.10$0.02 | +5400.0% |
| Shares Outstanding (Basic) | 723.20M775.40M | −6.7% |
| Shares Outstanding (Diluted) | 728.40M781.20M | −6.8% |
05—Questions
Frequently Asked Questions
What was MetLife's net income available to common shareholders in Q1 2024 and how does it compare to the previous year?
MetLife's net income available to common shareholders was $800 million for the three months ended March 31, 2024, a significant increase from $14 million reported for the same period in 2023. This improvement was primarily driven by a favorable change in net investment gains (losses) and net derivative gains (losses), as well as a positive swing in market risk benefit remeasurements.
How did MetLife's adjusted earnings perform in Q1 2024?
MetLife's adjusted earnings available to common shareholders were $1.33 billion for the first quarter of 2024, an increase of $150 million compared to $1.18 billion in the first quarter of 2023. This growth was attributed to a combination of favorable market factors, volume growth across several segments, and improved underwriting experience, partially offset by higher expenses and the impact of a prior reinsurance transaction.
What is the current state of MetLife's investment portfolio and its impact on financial results?
MetLife's investment portfolio remains diversified, with a strong weighting towards fixed income securities. As of March 31, 2024, total investments were $440.0 billion. Net investment income increased to $5.44 billion in Q1 2024 from $4.65 billion in Q1 2023, reflecting higher yields on fixed income securities and mortgage loans, and improved returns on private equity funds. However, net investment gains (losses) were $(375) million in Q1 2024, compared to $(684) million in Q1 2023, indicating continued volatility from market factors.
How is MetLife managing its capital and returning value to shareholders?
MetLife continues to actively manage its capital. During Q1 2024, the company repurchased approximately $1.17 billion of its common stock. Additionally, MetLife's Board of Directors authorized an additional $3.0 billion of common stock repurchases in May 2024. The company also declared preferred stock dividends of $67 million and common stock dividends of $377 million in Q1 2024.
06—Continue